Literature DB >> 12892196

Endoprosthetic replacement of the proximal humerus. Long-term results.

D Kumar1, R J Grimer, A Abudu, S R Carter, R M Tillman.   

Abstract

We studied 100 patients who had undergone endoprosthetic replacement of the proximal humerus between 1976 and 1998. The outcome was assessed with regard to the survivorship of the patients, the salvaged limbs and the prostheses. Function was determined in the 47 surviving patients, of whom 30 were assessed using the Musculo-Skeletal Tumour Society (MSTS) rating scale and 38 completed the Toronto Extremity Salvage Score (TESS) questionnaire. The median age of the patients was 34 years (10 to 80). The mean follow-up period for surviving patients was nine years (2 to 20). The mean MSTS score at follow-up was 79% and the mean TESS score was 72%. The length of bone which was resected influenced the functional outcome. Abduction of the shoulder was to 45 degrees in most patients. The overall survival was 42% at ten years and that of the limb without amputation 93%. The survival of the prostheses using mechanical failure as the endpoint was 86.5% at 20 years. Endoprosthetic replacement of the proximal humerus is a predictable procedure providing reasonable function of the arm with a low rate of complications at long-term follow-up.

Entities:  

Mesh:

Year:  2003        PMID: 12892196

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  29 in total

Review 1.  Management of infection following reconstruction in bone tumors.

Authors:  Sudhir K Kapoor; Rajesh Thiyam
Journal:  J Clin Orthop Trauma       Date:  2015-07-07

Review 2.  Silver-coated megaprostheses: review of the literature.

Authors:  Tom Schmidt-Braekling; Arne Streitbuerger; Georg Gosheger; Friedrich Boettner; Markus Nottrott; Helmut Ahrens; Ralf Dieckmann; Wiebke Guder; Dimosthenis Andreou; Gregor Hauschild; Burkhard Moellenbeck; Wenzel Waldstein; Jendrik Hardes
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-06

3.  Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.

Authors:  Krista A Goulding; Adam Schwartz; Steven J Hattrup; R Lor Randall; Donald Lee; Damian M Rispoli; Daniel M Lerman; Christopher Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

Review 4.  [Management of complications in megaprostheses].

Authors:  J Hardes; H Ahrens; G Gosheger; M Nottrott; R Dieckmann; M-P Henrichs; A Streitbürger
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

5.  [Modular tumor prostheses of the humerus].

Authors:  P T Funovics; M Dominkus
Journal:  Orthopade       Date:  2010-10       Impact factor: 1.087

6.  Silver-coated endoprosthetic replacement of the proximal humerus in case of tumour-is there an increased risk of periprosthetic infection by using a trevira tube?

Authors:  Jan Schmolders; Sebastian Koob; Paul Schepers; Michael Kehrer; Sönke Percy Frey; Dieter Christian Wirtz; Peter Heinrich Pennekamp; Andreas Christian Strauss
Journal:  Int Orthop       Date:  2016-11-09       Impact factor: 3.075

7.  Endoprosthetic replacement of diaphyseal bone defects. Long-term results.

Authors:  E Aldlyami; A Abudu; R J Grimer; S R Carter; R M Tillman
Journal:  Int Orthop       Date:  2005-01-05       Impact factor: 3.075

8.  Does total humeral endoprosthetic replacement provide reliable reconstruction with preservation of a useful extremity?

Authors:  Hazem Wafa; Krishna Reddy; Robert Grimer; Adesegun Abudu; Lee Jeys; Simon Carter; Roger Tillman
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

Review 9.  Outcome after reconstruction of the proximal humerus for tumor resection: a systematic review.

Authors:  Teun Teunis; Sjoerd P F T Nota; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón
Journal:  Clin Orthop Relat Res       Date:  2014-01-28       Impact factor: 4.176

10.  Proximal humerus reconstructions for tumors.

Authors:  Benjamin K Potter; Sheila C Adams; J David Pitcher; Theodore I Malinin; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2008-09-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.